# Adaptimmune Therapeutics PLC: Form 20-F for the period ended Dec 31, 2015

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 20-F
- Filed: 2016-03-17
- Accepted by EDGAR: Mar 17, 2016, 07:38 ET
- Period: 2015-12-31
- Accession: 0001104659-16-105686
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000110465916105686/a16-5330_120f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000110465916105686/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000110465916105686/a16-5330_120f.htm

Filed Mar 17, 2016.
Source: SEC EDGAR, the filing index for accession 0001104659-16-105686. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.
